EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment

Lung cancer is a leading cause of cancer-related deaths worldwide. About 10–30% of patients with non-small cell lung cancer (NSCLC) harbor mutations of the EGFR gene. The Tumor Microenvironment (TME) of patients with NSCLC harboring EGFR mutations displays peculiar characteristics and may modulate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Madeddu, Clelia, Donisi, Clelia, Liscia, Nicole, Lai, Eleonora, Scartozzi, Mario, Macciò, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224267/
https://www.ncbi.nlm.nih.gov/pubmed/35742933
http://dx.doi.org/10.3390/ijms23126489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224267/
https://www.ncbi.nlm.nih.gov/pubmed/35742933
http://dx.doi.org/10.3390/ijms23126489

Ejemplares similares